Prediagnostic Helicobacter pylori Antibodies and Colorectal Cancer Risk in an Elderly, Caucasian Population

Helicobacter

Volumn 21, Issue 6, 2016, Pages 488-492

  Blase, Jennifer L ^a   Campbell, Peter T ^a   Gapstur, Susan M ^a   Pawlita, Michael ^b   Michel, Angelika ^b   Waterboer, Tim ^b   Teras, Lauren R ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Caucasian; Colorectal cancer; elderly; Helicobacter pylori; infectious cancer etiology; prospective

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAGA PROTEIN; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CATALASE; CHAPERONIN 60; OUTER MEMBRANE PROTEIN; PROTEIN CAGM; PROTEIN HCPC; PROTEIN HOMB; PROTEIN HP0231; PROTEIN HP0305; PROTEIN HPAA; PROTEIN HYUA; PROTEIN NAPA; PROTEIN UREA; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; COLORECTAL NEOPLASMS; COMPLICATION; FEMALE; HELICOBACTER INFECTIONS; IMMUNOLOGY; MALE; MIDDLE AGED; RISK ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84961783920     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12305     Document Type: Article

References (30)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum (vol. 100B). 2012/11/30 edn. WHO Press, World Health Organization, Switzerland, 2012; pp. 385–435.
2. Papastergiou V, Karatapanis S, Georgopoulos SD. Helicobacter pylori and colorectal neoplasia: is there a causal link?. World Journal of Gastroenterology. 2015;22:649–658.
3. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 1993;105:22–30.
4. Renga M, Brandi G, Paganelli G, Calabrese C, Papa S, Tosti A, Tomassetti P, Miglioli M, Biasco G. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut 1997;41:330–2.
5. Koh TJ, Dockray GJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Wang TC. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Invest 1999;103:1119–26.
6. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, Dockray GJ. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918.
7. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006;74:42–6.
8. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998;115:275–80.
9. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014;15:317–28.
10. Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 2006;66:828–38.
11. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol 2011;12:504–12.
12. Maddocks OD, Short AJ, Donnenberg MS, Bader S, Harrison DJ. Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans. PLoS One 2009;4:e5517.
13. Maeda S, Mentis AF. Pathogenesis of Helicobacter pylori infection. Helicobacter 2007;12(Suppl 1):10–4.
14. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332–5.
15. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013;108:208–15.
16. Rokkas T, Sechopoulos P, Pistiolas D, Kothonas F, Margantinis G, Koukoulis G. The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis. Eur J Gastroenterol Hepatol 2013;25:1286–94.
17. Epplein M, Pawlita M, Michel A, Peek RM Jr, Cai Q, Blot WJ. Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013;22:1964–74.
18. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005;3:320–32.
19. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002;94:2490–501.
20. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;14:525–35.
21. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, et al. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002;11(10 Pt 1):1095–9.
22. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998;115:275–80.
23. Epplein M, Signorello LB, Zheng W, Peek RM Jr, Michel A, Williams SM, Pawlita M, Correa P, Cai Q, Blot WJ. Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev 2011;20:826–34.
24. Guo Y, Li HY. Association between Helicobacter pylori infection and colorectal neoplasm risk: a meta-analysis based on East Asian population. J Cancer Res Ther 2014;10(Suppl):263–6.
25. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001;96:3406–10.
26. Hartwich J, Konturek SJ, Pierzchalski P, Zuchowicz M, Konturek PC, Bielanski W, Marlicz K, Starzynska T, Lawniczak M. Molecular basis of colorectal cancer – role of gastrin and cyclooxygenase-2. Med Sci Monit 2001;7:1171–81.
27. Brim H, Zahaf M, Laiyemo AO, Nouraie M, Perez-Perez GI, Smoot DT, Lee E, Razjouyan H, Ashktorab H. Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans. BMC Cancer 2014;14:296.
28. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005;117:1058–9.
29. Patel S, Lipka S, Shen H, Barnowsky A, Silpe J, Mosdale J, Pan Q, Fridlyand S, Bhavsar A, Abraham A. The association of H. pylori and colorectal adenoma: does it exist in the US Hispanic population? J Gastrointest Oncol 2014;5:463–8.
30. Selgrad M, Bornschein J, Kandulski A, Hille C, Weigt J, Roessner A, Wex T, Malfertheiner P. Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms. Int J Cancer 2014;135:1127–31.